Although Bcl-2 is an anti-apoptotic protein, high Bcl-2 expression has been observed in ER-positive breast cancers [4,8,13,14,18,20,23,27-38], as well as in progesterone receptor (PR)-positive breast cancers [4,13,14,27-31,33-39], and has been associated with improved survival in breast cancer [4-24,40]. The gene discussed is BCL2; the disease is breast cancer.